Valirx - Overview

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Registrars: Capita Registrars

Key Personnel

CFO: Gerald Desler
Non-Executive Director: Adrian de Courcey
Executive Director: Cathy Tralau-Stewart, Tralau Stewart
Non-Executive Chairman: Martin Gouldstone
Chief Executive Officer : Mark Eccleston

Contact Details

Address: Stonebridge House, Chelmsford Road, Hatfield Heath, United Kingdom
Phone:
Fax:
Website: http://www.valirx.com
Email:

Listings

ISIN: GB00BLH13C52
Sector: Pharma and Biotech, Pharma and Biotech
Main Indices: FTSE AIM All-Share